Mirae Asset Global Investments Co. Ltd. increased its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 0.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 159,608 shares of the semiconductor company’s stock after purchasing an additional 1,045 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Synopsys were worth $77,924,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the stock. Hazlett Burt & Watson Inc. boosted its stake in shares of Synopsys by 40.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after buying an additional 20 shares during the last quarter. Caprock Group LLC boosted its position in Synopsys by 0.5% in the fourth quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company’s stock worth $1,803,000 after purchasing an additional 20 shares during the last quarter. Aptus Capital Advisors LLC grew its stake in shares of Synopsys by 1.5% during the 3rd quarter. Aptus Capital Advisors LLC now owns 1,447 shares of the semiconductor company’s stock valued at $733,000 after purchasing an additional 22 shares during the period. Resurgent Financial Advisors LLC increased its position in shares of Synopsys by 2.8% during the 3rd quarter. Resurgent Financial Advisors LLC now owns 809 shares of the semiconductor company’s stock valued at $410,000 after purchasing an additional 22 shares during the last quarter. Finally, Larson Financial Group LLC lifted its stake in shares of Synopsys by 6.1% in the 3rd quarter. Larson Financial Group LLC now owns 398 shares of the semiconductor company’s stock worth $202,000 after purchasing an additional 23 shares during the period. Institutional investors own 85.47% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on SNPS shares. Needham & Company LLC restated a “buy” rating and set a $640.00 target price on shares of Synopsys in a research report on Thursday, December 5th. Piper Sandler reduced their price objective on Synopsys from $670.00 to $655.00 and set an “overweight” rating for the company in a research note on Friday, December 6th. Mizuho assumed coverage on Synopsys in a research report on Tuesday, October 22nd. They set an “outperform” rating and a $650.00 target price on the stock. Robert W. Baird reduced their price target on Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Finally, Redburn Atlantic started coverage on Synopsys in a research report on Monday, January 13th. They set a “buy” rating and a $600.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $641.82.
Insiders Place Their Bets
In other news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.66% of the company’s stock.
Synopsys Stock Performance
Shares of NASDAQ:SNPS opened at $523.88 on Wednesday. The firm has a market cap of $80.98 billion, a price-to-earnings ratio of 36.08, a P/E/G ratio of 3.44 and a beta of 1.12. The firm has a fifty day moving average price of $515.42 and a 200 day moving average price of $519.67. Synopsys, Inc. has a fifty-two week low of $457.52 and a fifty-two week high of $629.38.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- What is an Earnings Surprise?
- 2 High-Yield Consumer Staples Stocks Ready to Deliver Big Returns
- Short Selling: How to Short a Stock
- Atlassian: Upside Still in Play After Impressive Earnings Spike
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.